|
|
 |
|
Viewing report
|
|
|
|
Injectable Drug Delivery: Market Impact and Industry Trends
Arrowhead Publishers, Oct 2006
As competition in the pharmaceutical marketplace grows, companies are increasingly looking towards the drug delivery industry to maximize revenues and combat generic competitors. The search for more efficient drug delivery systems is also being driven by the rise in patient demand, healthcare and pharma cost containment, as much as by medical and technological advances.
The global market for drug delivery technology is worth in excess of US$25 billion in sales. Given its predicted annual growth of 15 percent, the market represents a considerable business opportunity, which has been reflected in the increasing number of drug delivery specialists. According to our new report entitled Injectable Drug Delivery: Market Impact and Industry Trends, injectables currently account for an estimated 15 percent of the global drug delivery market, with the US being the leading individual market.
Key features of this report:
- Overview of the drug delivery environment
- In-depth analysis of the injectable drug delivery industry, including main types and main marketed
systems, and their advantages and disadvantages
- Comprehensive facts and figures for the injectable drug delivery market, including main players and key
therapeutic areas
- Future trends in the injectables marketplace, shaped by medical and technological advances as much as
demographic and epidemiological changes and industry needs
- Outlook for the injectable drug delivery technology
Who should buy this report?
- Stakeholders in the injectable drug delivery market
- Companies interested in understanding the impact and implications of securing the correct injectable drug
delivery technology in terms of product placement, lifecycle management and competition in the
marketplace
- Companies interested in understanding future opportunities in the injectable drug delivery sector provided
by a combination of factors, including changing public health needs
- Pharma/biotech companies wishing to identify potential injectable drug delivery areas for partnerships
and collaboration in order to examine a variety of profit maximization strategies
Products Mentioned
- Cimzia (Nektar)
- Mircera/CERA (Nektar)
- Paliperidone Palmitate (Johnson & Johnson)
- Intraject Sumatriptan (Zogenix)
- Neulasta (Nektar/Amgen)
- PEGASYS (Roche/Nektar)
- PEG-Intron (Schering-Plough)
- Risperdal Consta
- Sandostatin (Novartis)
- Vivitrol (Alkermes)
Customers who bought this item also bought
Drug Delivery Partnering Terms and Agreements in Pharma and Biotech 2nd Edition
Drug Delivery Systems: US Market Outlook, Advances for Pharma, Biotech & Medical Devices
Nanobiotechnology Applications, Markets and Companies
Opportunities in Non-Surgical Bio-Implants: Marketed Injectable Biomaterials, Applications, and Leading Players
G-Protein Coupled Receptors (GPCRs) - Global Strategic Business Report
Biologics Pipelines: Who Has the Next Promising Recombinant Proteins?
Biotech Investment and Business Trends: Weathering the Economic Storm
Biopharmaceuticals - A Global Market Overview
RNAi - Technologies, Markets and Companies
Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma
|
|
|
|
